Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
87.8M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
5.06M
-
Shares change
-
-97.9K
-
Total reported value, excl. options
-
$9.61M
-
Value change
-
-$263K
-
Number of buys
-
11
-
Number of sells
-
-11
-
Price
-
$1.90
Significant Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) as of Q3 2022
32 filings reported holding CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q3 2022.
COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.06M shares
of 87.8M outstanding shares and own 5.76% of the company stock.
Largest 10 shareholders include PATHSTONE FAMILY OFFICE, LLC (2.21M shares), AIGH Capital Management LLC (798K shares), VANGUARD GROUP INC (401K shares), Voss Capital, LLC (219K shares), COMMONWEALTH EQUITY SERVICES, LLC (219K shares), AMERICAN FINANCIAL GROUP INC (205K shares), Worth Venture Partners, LLC (200K shares), P.A.W. CAPITAL CORP (100K shares), CARLSON CAPITAL L P (100K shares), and GEODE CAPITAL MANAGEMENT, LLC (80.4K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.